JucaBio

Health Care

Overview

Innovative Science Meets Acceleration™. We are a team of experienced drug developers focused on designing efficient clinical development plans to quickly demonstrate the value of drugs that address significant unmet medical needs.

Funding and backers

Total raised
$3.8M
1 round on record
Latest round
$3.8M
Venture round · Dec 2024 · 22 mo ago
Team
11-50
employees, estimated range
The money's age
Due for its next round
22 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 16, 2024 Raised a round Venture round $3.8M · SEC Form D 2023 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Dec 2024 $3.8M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity JucaBio LLC SEC Form D
Founders and leadersfrom filings, registers and the company's site
Catherine PearceExecutive Officer, DirectorSEC Form D
Justin ThompsonExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Inveready
backs Ability Pharma, Iteria Biopharma
RA Capital Management
backs Angitia Biopharmaceuticals
Wellington Management
backs Angitia Biopharmaceuticals
OrbiMed
backs Angitia Biopharmaceuticals
Imperial College London
backs OMNICYTE
Amino Collective
backs Scale Medicine
Similar startupsby what they do, their industry and backers
Scale MedicineConvertible Note $2M · 2 yr ago · Founded 2023 · 1-10 employees
The decision platform for drug developers.
OMNICYTE1-10 employees
OmniCyte is a pre-clinical biotech company addressing significant unmet needs in cancer.
Optimeos501-1000 employees
About the technology. Optimeos is developing a solution suite to overcome crucial formulation challenges and address unmet medical needs.
Starton Therapeutics
Determined to address unmet medical needs The FDA defines unmet medical need for cancer as a serious condition that is not adequately…
PROSIONVenture round · 3 yr ago · Founded 2020
PROSION Therapeutics is a drug development company that utilises cutting-edge technology to unlock so far undruggable targets and address…
Ability Pharma201-500 employees
"We are committed to creating the future of oncology by developing innovative therapies inducing autophagy to address unmet medical needs".

Financials

Total raised
$3.8M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $3.8M Details

People

Catherine Pearce
Executive Officer, Director
SEC Form D
Justin Thompson
Executive Officer, Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cincinnati United States
HQ
10-50 est. staff